Key result
In a mouse model of repetitive ischemia/reperfusion, downregulation of PPARalpha was mediated by reactive oxygen species and served as an adaptive mechanism to prevent cardiac lipotoxicity.
Why the study?
Does downregulation of PPARalpha prevent lipotoxicity and maintain contractile function in a mouse model of repetitive ischemia/reperfusion?
Does downregulation of PPARalpha prevent lipotoxicity and maintain contractile function in a mouse model of repetitive ischemia/reperfusion?
Downregulation of PPARalpha during repetitive ischemia/reperfusion is a reactive oxygen species-dependent adaptive mechanism that prevents cardiac lipotoxicity.
Answers are grounded in this paper and cite their sources.
ROS-mediated PPARalpha downregulation may prevent lipotoxicity in repetitive I/R; hypothesis-generating in mice, no clinical implications yet.
BACKGROUND: The peroxisome proliferators-activated receptor-alpha (PPARalpha), a transcription factor that modulates fatty acid metabolism, regulates substrate preference in the heart. Although in acute ischemia there is a switch in substrate preference from fatty acids to glucose, metabolic gene expression in repetitive ischemia is not well described. In a mouse model of ischemic cardiomyopathy induced by repetitive ischemia/reperfusion (I/R), we postulated that downregulation of PPARalpha is regulated by reactive oxygen species and is necessary for maintaining contractile function in the heart. METHODS AND RESULTS: Repetitive closed-chest I/R (15 minutes) was performed daily in C57/BL6 mice, mice overexpressing extracellular superoxide dismutase, and mice treated with the PPARalpha agonist-WY-14,643. Echocardiography, histology, and candidate gene expression were measured at 3, 5, 7, and 28 days of repetitive I/R and 15 and 30 days after discontinuation of I/R. Repetitive I/R was associated with a downregulation of PPARalpha-regulated genes and both myosin heavy chain isoform transcript levels, which was reversible on discontinuation of I/R. Overexpression of EC-SOD prevented the downregulation of PPARalpha-regulated genes and myosin iso-genes by repetitive I/R. Furthermore, reactivation of PPARalpha in mice exposed to repetitive I/R worsened contractile function, induced microinfarctions, and increased intramyocardial triglyceride deposition, features suggestive of cardiac lipotoxicity. CONCLUSIONS: Metabolic and myosin isoform gene expression in repetitive I/R is mediated by reactive oxygen species. Furthermore, we suggest that downregulation of PPARalpha in repetitive I/R is an adaptive mechanism that is able to prevent lipotoxicity in the ischemic myocardium.
No takes yet. Share an insight, caveat, or question.
Dewald et al. (2005) studied Ischemic cardiomyopathy. Repetitive ischemia/reperfusion (I/R) vs. Discontinuation of I/R, overexpression of EC-SOD, or PPARalpha agonist WY-14,643 was evaluated on Echocardiography, histology, and candidate gene expression. In a mouse model of repetitive ischemia/reperfusion, downregulation of PPARalpha was mediated by reactive oxygen species and served as an adaptive mechanism to prevent cardiac lipotoxicity.
Synapse has enriched 10 related papers. Consider them for comparative context: